Written by MarketBeatSeptember 21, 2025 ShareLink copied to clipboard. Key Points Eli Lilly, AbbVie, and D-Wave Quantum are highlighted as top pharmaceutical stocks to watch, driven by high trading volumes and significant developments. Eli Lilly has potential breakthroughs in diabetes and obesity treatments, reflecting the company's commitment to innovative pharmaceuticals. AbbVie continues to expand its portfolio with treatments for autoimmune diseases and blood cancers, maintaining its focus on diverse therapeutic areas. Five stocks we like better than Eli Lilly and Company. Like this article? Share it with a colleague. Link copied to clipboard. Featured Articles and OffersBigBear.ai (NYSE:BBAI) Shares Acquired Rep. Lisa C. McClainBy MarketBeat | September 19, 2025The End of Elon Musk…?From Brownstone Research (Ad)Oracle (NYSE:ORCL) Director Sells $3,519,000.00 in StockBy MarketBeat | September 19, 2025D-Wave Quantum (NYSE:QBTS) Trading 18.5% Higher - Should You Buy?By MarketBeat | September 20, 20253 AI Infrastructure Stocks With Upside After the Summer RallyBy Chris Markoch | September 18, 2025Prepare for the “Mar-a-Lago Accord” Money ShockFrom Stansberry Research (Ad)NIO's New Dawn: Why Wall Street's Bullish Turn Signals a ComebackBy Jeffrey Neal Johnson | September 19, 2025Biotech Breakouts: 3 Stocks With Massive Upside PotentialBy Chris Markoch | September 17, 2025 Recent Videos Stock ListsAll Stock Lists5G Biotech Blue Chip FAANG Gold Large Cap Marijuana Micro Cap Oil REITs Russell 2000 Small Cap Warren Buffett Investing ToolsCalendars and ToolsAnalyst RatingsCryptocurrency ScreenerCongressional TradingDividend IncreasesDividend CalculatorDividend CalendarEarnings AnnouncementsInsider TradesOptions Profit CalculatorPenny StocksPortfolio MonitoringShort InterestStock ComparisonsStock Market HolidaysStock Screener Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Written by MarketBeatSeptember 21, 2025 ShareLink copied to clipboard. Key Points Eli Lilly, AbbVie, and D-Wave Quantum are highlighted as top pharmaceutical stocks to watch, driven by high trading volumes and significant developments. Eli Lilly has potential breakthroughs in diabetes and obesity treatments, reflecting the company's commitment to innovative pharmaceuticals. AbbVie continues to expand its portfolio with treatments for autoimmune diseases and blood cancers, maintaining its focus on diverse therapeutic areas. Five stocks we like better than Eli Lilly and Company. Like this article? Share it with a colleague. Link copied to clipboard.
